Lee Danner & Bass Inc. Purchases 5,426 Shares of Danaher Corporation $DHR

Lee Danner & Bass Inc. grew its position in Danaher Corporation (NYSE:DHRFree Report) by 30.6% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 23,175 shares of the conglomerate’s stock after purchasing an additional 5,426 shares during the quarter. Lee Danner & Bass Inc.’s holdings in Danaher were worth $4,394,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in DHR. Elevated Capital Advisors LLC bought a new position in Danaher in the fourth quarter valued at approximately $26,000. Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd lifted its stake in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares during the last quarter. JPL Wealth Management LLC bought a new stake in Danaher during the third quarter worth $25,000. Finally, WFA of San Diego LLC acquired a new stake in shares of Danaher in the 2nd quarter valued at $26,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.0%

Shares of DHR opened at $197.85 on Friday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The stock has a market capitalization of $140.03 billion, a price-to-earnings ratio of 38.27, a PEG ratio of 2.52 and a beta of 0.79. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock has a fifty day moving average of $179.01 and a 200-day moving average of $200.54.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the previous year, the company posted $1.88 EPS. Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.44 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. DZ Bank initiated coverage on Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective on the stock. Morgan Stanley decreased their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Royal Bank Of Canada started coverage on Danaher in a research report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 target price on the stock. Finally, Rothschild & Co Redburn set a $205.00 target price on Danaher in a research note on Friday, April 17th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $233.61.

Get Our Latest Analysis on DHR

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.